Skip to content

Clinical trials

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Country / region: Switzerland Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20052
20072
20101
20172
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Cellestia Biotech AG1
Children's Oncology Group1
German High-Grade Non-Hodgkin's Lymphoma Study Group1
National Cancer Institute (NCI)1
Oncology Institute of Southern Switzerland1
Princess Maxima Center for Pediatric Oncology1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma11
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Burkitt Lymphoma7
Lymphoma, Follicular7
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Mantle-Cell7
Hodgkin Disease6
Lymphoma, B-Cell, Marginal Zone6
Lymphoma, Large-Cell, Anaplastic6
Lymphoma, Non-Hodgkin6

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.